Muntener, Michael; Epstein, Jonathan I; Hernandez, David J et al. (2008) Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. Eur Urol 53:767-75;discussion 775-6
|
Nielsen, Matthew E; Han, Misop; Mangold, Leslie et al. (2006) Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. J Urol 176:515-9
|
Nelson, W G; De Marzo, A M; DeWeese, T L (2001) The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. Urology 57:39-45
|
Nelson, W G; De Marzo, A M; Deweese, T L et al. (2001) Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci 952:135-44
|
Roberts, W W; Bergstralh, E J; Blute, M L et al. (2001) Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 57:1033-7
|
Han, M; Partin, A W; Pound, C R et al. (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28:555-65
|
Feneley, M R; Partin, A W (2001) Indicators of pathologic stage of prostate cancer and their use in clinical practice. Urol Clin North Am 28:443-58
|
Han, M; Piantadosi, S; Zahurak, M L et al. (2001) Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer. Urology 57:707-11
|
Zhang, Q; Wang, Y C; Montalvo, E A (1999) Smubp-2 represses the Epstein-Barr virus lytic switch promoter. Virology 255:160-70
|
Pound, C R; Partin, A W; Eisenberger, M A et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-7
|
Showing the most recent 10 out of 14 publications